Asthma and Copd
April 2 - 3, 2014 - Marriott Regents Park Hotel, London NW3 3ST UKSMi Group Ltd
fbegum@smi-online.co.uk
Phone:44 020 7827 6184
The global market for Asthma and COPD drugs is set to reach $47bn in 2017. There is a growing demand for the next generation of inhaled combination products and novel therapeutics. Asthma and COPD 2014 will enable delegates to gain valuable insights into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.
This website uses cookies to ensure you get the best experience on our website. Learn more